{
  "id": 15832743,
  "title": "New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery",
  "url": "https://urgent.news/2026/10/21/new-drug-could-let-some-rectal-cancer-patients-skip-chemotherapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-21T01:20:09.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-drug-rectal-cancer-patients-chemotherapy.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for certain adults with rectal cancer that hasn't been treated yet.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}